Technical Analysis for PRFX - PainReform Ltd.
Grade | Last Price | % Change | Price Change |
---|---|---|---|
F | 0.45 | -10.02% | -0.05 |
PRFX closed down 10.02 percent on Friday, November 1, 2024, on 30 percent of normal volume. The bears made the stock sink to a new 52-week low. Note that the stock is in oversold territory based on its Slow Stochastic indicator (14, 3, 3) -- so don't be surprised if it goes sideways or bounces.
Earnings due: Nov 13
*** please verify all earnings dates ***ADX | Long Term | Intermediate Term | Short Term |
---|---|---|---|
Weak or Absent | Down | Down | Down |
Date | Alert Name | Type | % Chg |
---|---|---|---|
New 52 Week Closing Low | Bearish | 0.00% | |
Lower Bollinger Band Walk | Weakness | 0.00% | |
New 52 Week Low | Weakness | 0.00% | |
Wide Bands | Range Expansion | 0.00% | |
Below Lower BB | Weakness | 0.00% | |
Lower Bollinger Band Touch | Weakness | 0.00% | |
Oversold Stochastic | Weakness | 0.00% | |
New 52 Week Closing Low | Bearish | -10.02% | |
New 52 Week Low | Weakness | -10.02% | |
Wide Bands | Range Expansion | -10.02% |
Alert | Time |
---|---|
Down 10% | about 20 hours ago |
60 Minute Opening Range Breakdown | about 23 hours ago |
Down 5% | about 23 hours ago |
Down 3% | 1 day ago |
Rose Above Lower Bollinger Band | 1 day ago |
Free Daily (Stock) Chart Reading
Let us help you stay on top of your investments. We will alert you to important technical developments on your
portfolio & watchlist.
Configure default chart indicators
Basic chart:
- Earnings date: 11/13/2024
PainReform Ltd. operates as a pharmaceutical company. It develops and markets pharmaceuticals. The firm focuses on developing reformulation of pain therapeutics, PainReform applies its propriety formulation technologies to prolong and enhance efficacy, reduce adverse effects shortening recovery time and reduce the need of augmentation with drugs such as opioids and NSAIDS. The company was founded by Lihu Avitov and Dan Teleman in 2007 and is headquartered in Herzliya, Israel.
Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Keywords: Pharmaceutical Pharmacy Opioids Pharmaceutical Sciences Hepatotoxins Nonsteroidal Anti Inflammatory Drug
Classification
Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Keywords: Pharmaceutical Pharmacy Opioids Pharmaceutical Sciences Hepatotoxins Nonsteroidal Anti Inflammatory Drug
Indicator | Bull Case | Neutral / Hold | Bear Case |
---|---|---|---|
50 DMA | |||
200 DMA | |||
ADX Trend | |||
Oversold / Overbought | |||
Relative Strength |
Indicator | Value |
---|---|
52 Week High | 20.16 |
52 Week Low | 0.4318 |
Average Volume | 480,627 |
200-Day Moving Average | 5.25 |
50-Day Moving Average | 0.85 |
20-Day Moving Average | 0.63 |
10-Day Moving Average | 0.63 |
Average True Range | 0.10 |
RSI (14) | 31.51 |
ADX | 21.84 |
+DI | 20.31 |
-DI | 31.95 |
Chandelier Exit (Long, 3 ATRs) | 0.58 |
Chandelier Exit (Short, 3 ATRs) | 0.72 |
Upper Bollinger Bands | 0.79 |
Lower Bollinger Band | 0.47 |
Percent B (%b) | -0.06 |
BandWidth | 51.46 |
MACD Line | -0.09 |
MACD Signal Line | -0.09 |
MACD Histogram | 0.0014 |
Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
---|---|---|---|---|---|
Resistance 4 (R4) | 0.55 | ||||
Resistance 3 (R3) | 0.56 | 0.53 | 0.54 | ||
Resistance 2 (R2) | 0.53 | 0.50 | 0.53 | 0.53 | |
Resistance 1 (R1) | 0.49 | 0.49 | 0.47 | 0.48 | 0.52 |
Pivot Point | 0.46 | 0.46 | 0.45 | 0.46 | 0.46 |
Support 1 (S1) | 0.42 | 0.43 | 0.41 | 0.42 | 0.38 |
Support 2 (S2) | 0.39 | 0.42 | 0.39 | 0.37 | |
Support 3 (S3) | 0.35 | 0.39 | 0.36 | ||
Support 4 (S4) | 0.35 |